Alternatively spliced variants of androgen receptor in granulosa cells: an epigenetic cause of ovarian hyperandrogenism of polycystic ovary syndrome
f f wang,j x pan,yonggang liu,quan meng,j z sheng,h f huang
DOI: https://doi.org/10.1016/j.fertnstert.2013.07.127
IF: 6.7
2013-01-01
Fertility and Sterility
Abstract:ObjectiveTo identify alternatively spliced variants of androgen receptor (AR) in granulosa cells (GCs) of polycystic ovary syndrome (PCOS) women, and to investigate their roles in ovarian hyperandrogenism.DesignCase-control study and basic science.Materials and Methods65 PCOS women and 150 women with tubal blockage undergoing IVF-ET in our center were recruited. GCs and follicular fluids were collected during oocyte retrieval. GCs of 60 patients with tubal blockage were primarily cultured. We performed RT-PCR, realtime PCR, DNA sequencing, ELISA, adenovirus construction and infections. One-way ANOVA and t test were used.Results(1) We found two abnormal alternatively spliced variants of AR in GCs, which comprised an insertion of a 69-bp fragment of intron2 or exon skipping of exon3; (2) All women expressed the wild type of AR variant, and their expression levels were comparable,however,insertion and deletion type were exclusively expressed in 50% and 14.7% of PCOS women separately; (3) For women with abnormal AR variant, serum total testosterone and dehydroepiandrosterone levels and free androgen index levels in follicular fluids were significantly higher compared with those without (P<0.05); (4)Since aromatase converts androgens into estrogens, lower mRNA expression of aromatase (CYP19A1) and reduced estradiol (E2)/TT and estrone/androstenedione (E1/A) ratio in follicular fluid were found in PCOS women with abnormal types of AR variant (P<0.05); (5) When infected in primary cultured GCs, both abnormal spliced variants showed dramatically decreased CYP19A1 mRNA level and E2/TT and E1/A ratio of culture media compared to wild type following dihydrotestosterone treatment (P<0.05).ConclusionOur findings strongly indicate abnormal alternatively spliced variants of AR as being an intrinsic epigenetic cause of androgen metabolism dysfunction in GCs, resulting in ovarian hyperandrogenism of PCOS. And our work to clarify its underlying mechanism is already under way. ObjectiveTo identify alternatively spliced variants of androgen receptor (AR) in granulosa cells (GCs) of polycystic ovary syndrome (PCOS) women, and to investigate their roles in ovarian hyperandrogenism. To identify alternatively spliced variants of androgen receptor (AR) in granulosa cells (GCs) of polycystic ovary syndrome (PCOS) women, and to investigate their roles in ovarian hyperandrogenism. DesignCase-control study and basic science. Case-control study and basic science. Materials and Methods65 PCOS women and 150 women with tubal blockage undergoing IVF-ET in our center were recruited. GCs and follicular fluids were collected during oocyte retrieval. GCs of 60 patients with tubal blockage were primarily cultured. We performed RT-PCR, realtime PCR, DNA sequencing, ELISA, adenovirus construction and infections. One-way ANOVA and t test were used. 65 PCOS women and 150 women with tubal blockage undergoing IVF-ET in our center were recruited. GCs and follicular fluids were collected during oocyte retrieval. GCs of 60 patients with tubal blockage were primarily cultured. We performed RT-PCR, realtime PCR, DNA sequencing, ELISA, adenovirus construction and infections. One-way ANOVA and t test were used. Results(1) We found two abnormal alternatively spliced variants of AR in GCs, which comprised an insertion of a 69-bp fragment of intron2 or exon skipping of exon3; (2) All women expressed the wild type of AR variant, and their expression levels were comparable,however,insertion and deletion type were exclusively expressed in 50% and 14.7% of PCOS women separately; (3) For women with abnormal AR variant, serum total testosterone and dehydroepiandrosterone levels and free androgen index levels in follicular fluids were significantly higher compared with those without (P<0.05); (4)Since aromatase converts androgens into estrogens, lower mRNA expression of aromatase (CYP19A1) and reduced estradiol (E2)/TT and estrone/androstenedione (E1/A) ratio in follicular fluid were found in PCOS women with abnormal types of AR variant (P<0.05); (5) When infected in primary cultured GCs, both abnormal spliced variants showed dramatically decreased CYP19A1 mRNA level and E2/TT and E1/A ratio of culture media compared to wild type following dihydrotestosterone treatment (P<0.05). (1) We found two abnormal alternatively spliced variants of AR in GCs, which comprised an insertion of a 69-bp fragment of intron2 or exon skipping of exon3; (2) All women expressed the wild type of AR variant, and their expression levels were comparable,however,insertion and deletion type were exclusively expressed in 50% and 14.7% of PCOS women separately; (3) For women with abnormal AR variant, serum total testosterone and dehydroepiandrosterone levels and free androgen index levels in follicular fluids were significantly higher compared with those without (P<0.05); (4)Since aromatase converts androgens into estrogens, lower mRNA expression of aromatase (CYP19A1) and reduced estradiol (E2)/TT and estrone/androstenedione (E1/A) ratio in follicular fluid were found in PCOS women with abnormal types of AR variant (P<0.05); (5) When infected in primary cultured GCs, both abnormal spliced variants showed dramatically decreased CYP19A1 mRNA level and E2/TT and E1/A ratio of culture media compared to wild type following dihydrotestosterone treatment (P<0.05). ConclusionOur findings strongly indicate abnormal alternatively spliced variants of AR as being an intrinsic epigenetic cause of androgen metabolism dysfunction in GCs, resulting in ovarian hyperandrogenism of PCOS. And our work to clarify its underlying mechanism is already under way. Our findings strongly indicate abnormal alternatively spliced variants of AR as being an intrinsic epigenetic cause of androgen metabolism dysfunction in GCs, resulting in ovarian hyperandrogenism of PCOS. And our work to clarify its underlying mechanism is already under way.